A web-based clinical prediction tool predicted 10 year survival in breast cancerPopulation-based validation of the prognostic model ADJUVANT for early breast cancer.

  • Williams, Chris MD (commentator)
  • Olivotto, IA
  • Bajdik, CD
  • Ravdin, PM
  • et al,

  • Bristol Haematology and Oncology Centre Bristol, UK

Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005; 23:2716–25.OlivottoIABajdikCDRavdinPMet alPopulation-based validation of the prognostic model ADJUVANT for early breast cancer.J Clin Oncol2005232716-25Q In women with stage I or II breast cancer, does the Adjuvant! web-based clinical prediction tool predict prognosis with and without adjuvant systemic therapy in terms of overall survival (OS), breast cancer specific survival (BCSS), and event free survival (EFS)?

For correspondence: Dr I A Olivotto, BC Cancer Agency, Victoria, British Columbia, Canada. [email protected]

Sources of funding: Canadian Breast Cancer Research Alliance and Michael Smith Foundation for Health Research.

Evidence Based Medicine 10(6):p 186, December 2005.

Clinical impact ratings Oncology ★★★★★★☆

Copyright © 2005 BMJ Publishing Group Ltd